{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:10:19Z","timestamp":1773871819674,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["96-14901"],"award-info":[{"award-number":["96-14901"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Premature ovarian failure is one of the major side effects of chemotherapy drugs. Blood plasma contains several factors that might lead to the repair of different tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The chemoprotective effects of plasma derived from mice with different ages and genders were assessed on ovarian tissue in cyclophosphamide-treated mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty-two adult female mice were divided into six groups as follows: (A) control; (B) 0.9% sodium chloride as vehicle; (C) cyclophosphamide; (D) cyclophosphamide + young male blood plasma; (E) cyclophosphamide + old male blood plasma; (F) cyclophosphamide + young female blood plasma. Ovarian failure was induced by injecting cyclophosphamide. On the 1st day, three groups received simultaneous injections of 150\u2009\u03bcL intraperitoneal and 70\u2009\u03bcL intravenous plasma derived from mice of different ages and genders. Each plasma type (150\u2009\u03bcL) was then injected intraperitoneally every other 3\u2009days for 19\u2009days. On day 21, the dissected ovaries were stained for stereological analysis. Also, estrogen and progesterone levels were measured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cyclophosphamide had damaging effects on ovarian parameters and led to reduced hormone levels in comparison with the control group. However, treating with young female and, old male blood plasma, to a lesser degree, showed beneficial effects on the number of primordial follicles, pre-antral follicles, and granulosa cells. Also, these two treatments had protective effects on the volume of ovarian parameters as well as estrogen and progesterone levels in comparison with the cyclophosphamide group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Plasma derived from mice of different ages and genders can ameliorate premature ovarian failure against the adverse effects of cyclophosphamide.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-020-00735-3","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T17:02:32Z","timestamp":1606323752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chemoprotective effects of plasma derived from mice of different ages and genders on ovarian failure after cyclophosphamide treatment"],"prefix":"10.1186","volume":"13","author":[{"given":"Soghra","family":"Bahmanpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisa","family":"Moradiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-7226","authenticated-orcid":false,"given":"Nehleh","family":"Zarei-fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"issue":"3","key":"735_CR1","first-page":"117","volume":"17","author":"B Meczekalski","year":"2018","unstructured":"Meczekalski B, Maciejewska-Jeske M, Podfigurna A. Reproduction in premature ovarian insufficiency patients - from latest studies to therapeutic approach. Prz Menopauzalny. 2018;17(3):117\u20139.","journal-title":"Prz Menopauzalny"},{"key":"735_CR2","first-page":"160026","volume":"2016","author":"AM Moreira","year":"2016","unstructured":"Moreira AM, Spritzer PM. Primary ovarian insufficiency: different approaches in three cases and a review of literature. Endocrinol Diabetes Metab Case Rep. 2016;2016:160026.","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"735_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/humupd\/dms022","volume":"18","author":"S Morgan","year":"2012","unstructured":"Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18(5):525\u201335.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"735_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/err.err_53_18","volume":"46","author":"R Ghaleb","year":"2019","unstructured":"Ghaleb R, Fahmy K. Premature ovarian failure in systemic lupus erythematosus patients: is it related to cyclophosphamide treatment? Egyptian Rheumatol Rehabil. 2019;46(2):85\u201391.","journal-title":"Egyptian Rheumatol Rehabil"},{"issue":"11","key":"735_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","volume":"6","author":"A Emadi","year":"2009","unstructured":"Emadi A, Jones RJ, Brodsky RA. Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol. 2009;6(11):638\u201347.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"735_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/humupd\/7.6.535","volume":"7","author":"D Meirow","year":"2001","unstructured":"Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7(6):535\u201343.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"735_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dmz027","volume":"25","author":"N Spears","year":"2019","unstructured":"Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson R, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25(6):673\u201393.","journal-title":"Hum Reprod Update"},{"issue":"6","key":"735_CR8","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/humrep\/deh257","volume":"19","author":"D Meirow","year":"2004","unstructured":"Meirow D, Assad G, Dor J, Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod. 2004;19(6):1294\u20139.","journal-title":"Hum Reprod"},{"issue":"5","key":"735_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/humrep\/dey045","volume":"33","author":"N Pascuali","year":"2018","unstructured":"Pascuali N, Scotti L, Di Pietro M, Oubi\u00f1a G, Bas D, May M, et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018;33(5):844\u201359.","journal-title":"Hum Reprod"},{"issue":"10","key":"735_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-1961-y","volume":"10","author":"G Bellusci","year":"2019","unstructured":"Bellusci G, Mattiello L, Iannizzotto V, Ciccone S, Maiani E, Villani V, et al. Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility. Cell Death Dis. 2019;10(10):1\u201314.","journal-title":"Cell Death Dis"},{"issue":"2","key":"735_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5653\/cerm.2018.45.2.67","volume":"45","author":"AS Dawood","year":"2018","unstructured":"Dawood AS, Salem HA. Current clinical applications of platelet-rich plasma in various gynecological disorders: an appraisal of theory and practice. Clin Exp Reprod Med. 2018;45(2):67\u201374.","journal-title":"Clin Exp Reprod Med."},{"issue":"1","key":"735_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5653\/cerm.2019.46.1.1","volume":"46","author":"SY Yoon","year":"2019","unstructured":"Yoon SY. Mesenchymal stem cells for restoration of ovarian function. Clin Exp Reprod Med. 2019;46(1):1\u20137.","journal-title":"Clin Exp Reprod Med"},{"issue":"12","key":"735_CR13","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1177\/1535370215576304","volume":"240","author":"NF Khedr","year":"2015","unstructured":"Khedr NF. Protective effect of mirtazapine and hesperidin on cyclophosphamide-induced oxidative damage and infertility in rat ovaries. Exp Biol Med. 2015;240(12):1682\u20139.","journal-title":"Exp Biol Med"},{"issue":"1","key":"735_CR14","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1530\/REP-17-0483","volume":"156","author":"B Fisch","year":"2018","unstructured":"Fisch B, Abir R. Female fertility preservation: past, present and future. Reproduction. 2018;156(1):F11\u201327.","journal-title":"Reproduction."},{"issue":"12","key":"735_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.18632\/aging.100105","volume":"1","author":"Y Niikura","year":"2009","unstructured":"Niikura Y, Niikura T, Tilly JL. Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging (Albany NY). 2009;1(12):971.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"735_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.18632\/aging.100255","volume":"2","author":"Y Niikura","year":"2010","unstructured":"Niikura Y, Niikura T, Wang N, Satirapod C, Tilly JL. Systemic signals in aged males exert potent rejuvenating effects on the ovarian follicle reserve in mammalian females. Aging (Albany NY). 2010;2(12):999.","journal-title":"Aging (Albany NY)"},{"key":"735_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.12688\/f1000research.11437.1","volume":"6","author":"AM Horowitz","year":"2017","unstructured":"Horowitz AM, Villeda SA. Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease. F1000Research. 2017;6:1291.","journal-title":"F1000Research"},{"issue":"4","key":"735_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.4103\/1673-5374.230277","volume":"13","author":"R Khoury","year":"2018","unstructured":"Khoury R, Ghossoub E. Young blood products: emerging treatment for Alzheimer's disease? Neural Regen Res. 2018;13(4):624.","journal-title":"Neural Regen Res"},{"key":"735_CR19","first-page":"5350960","volume":"2019","author":"D Aguirre-Valencia","year":"2019","unstructured":"Aguirre-Valencia D, Naranjo-Escobar J, Posso-Osorio I, Mac\u00eda-Mej\u00eda MC, Nieto-Aristiz\u00e1bal I, Barrera T, et al. Therapeutic plasma exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases. Autoimmune Dis. 2019;2019:5350960.","journal-title":"Autoimmune Dis"},{"issue":"CGM","key":"735_CR20","doi-asserted-by":"publisher","first-page":"S32797","DOI":"10.4137\/CGM.S32797","volume":"9","author":"HA Goubran","year":"2016","unstructured":"Goubran HA, Elemary M, Radosevich M, Seghatchian J, El-Ekiaby M, Burnouf T. Impact of transfusion on cancer growth and outcome. Cancer Growth Metastasis. 2016;9(CGM):S32797.","journal-title":"Cancer Growth Metastasis"},{"key":"735_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3389\/fphys.2019.00945","volume":"10","author":"V Pretini","year":"2019","unstructured":"Pretini V, Koenen MH, Kaestner L, Fens MH, Schiffelers RM, Bartels M, et al. Red blood cells: chasing interactions. Front Physiol. 2019;10:945.","journal-title":"Front Physiol"},{"issue":"1","key":"735_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000481828","volume":"45","author":"B Hofmann","year":"2018","unstructured":"Hofmann B. Young blood rejuvenates old bodies: a call for reflection when moving from mice to men. Transfus Med Hemother. 2018;45(1):67\u201371.","journal-title":"Transfus Med Hemother"},{"key":"735_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.aca.2018.03.009","volume":"1037","author":"X Liu","year":"2018","unstructured":"Liu X, Hoene M, Wang X, Yin P, H\u00e4ring H-U, Xu G, et al. Serum or plasma, what is the difference? Investigations to facilitate the sample material selection decision making process for metabolomics studies and beyond. Analytica Chimica Acta. 2018;1037:293\u2013300.","journal-title":"Analytica Chimica Acta"},{"issue":"8","key":"735_CR24","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/humrep\/dem137","volume":"22","author":"JS Charleston","year":"2007","unstructured":"Charleston JS, Hansen KR, Thyer AC, Charleston LB, Gougeon A, Siebert JR, et al. Estimating human ovarian non-growing follicle number: the application of modern stereology techniques to an old problem. Hum Reprod. 2007;22(8):2103\u201310.","journal-title":"Hum Reprod"},{"issue":"5","key":"735_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1530\/rep.1.00095","volume":"127","author":"M Myers","year":"2004","unstructured":"Myers M, Britt KL, Wreford NGM, Ebling FJP, Kerr JB. Methods for quantifying follicular numbers within the mouse ovary. Reproduction. 2004;127(5):569.","journal-title":"Reproduction"},{"issue":"2","key":"735_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/REP-09-0177","volume":"139","author":"RJ Rodgers","year":"2010","unstructured":"Rodgers RJ, Irving-Rodgers HF. Morphological classification of bovine ovarian follicles. Reproduction. 2010;139(2):309\u201318.","journal-title":"Reproduction."},{"issue":"4","key":"735_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1631\/jzus.B1200181","volume":"14","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Zhao J, Qi HJ, Li XL, Zhang SR, Song DW, et al. Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide. J Zhejiang Univ Sci B. 2013;14(4):318\u201324.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"7","key":"735_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0961203315622824","volume":"25","author":"J Mayorga","year":"2016","unstructured":"Mayorga J, Alp\u00edzar-Rodr\u00edguez D, Prieto-Padilla J, Romero-Diaz J, Cravioto M. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus. Lupus. 2016;25(7):675\u201383.","journal-title":"Lupus."},{"issue":"10","key":"735_CR29","first-page":"347","volume":"62","author":"J Wetzels","year":"2004","unstructured":"Wetzels J. Cyclophosphamide-induced gonadal toxicity: a treatment dilemma in patients with lupus nephritis. Neth J Med. 2004;62(10):347\u201352.","journal-title":"Neth J Med"},{"issue":"2","key":"735_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4103\/0378-6323.39696","volume":"74","author":"VA Saoji","year":"2008","unstructured":"Saoji VA. Premature ovarian failure due to cyclophosphamide: a report of four cases in dermatology practice. Indian J Dermatol Venereol Leprol. 2008;74(2):128.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"735_CR31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ijms17060836","volume":"17","author":"XY Chen","year":"2016","unstructured":"Chen XY, Xia HX, Guan HY, Li B, Zhang W. Follicle Loss and Apoptosis in Cyclophosphamide-Treated Mice: What's the Matter? Int J Mol Sci. 2016;17(6):836.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"735_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/toxsci\/kfm087","volume":"98","author":"M Tsai-Turton","year":"2007","unstructured":"Tsai-Turton M, Luong BT, Tan Y, Luderer U. Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. Toxicol Sci. 2007;98(1):216\u201330.","journal-title":"Toxicol Sci"},{"issue":"2\u20133","key":"735_CR33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/pmic.201400234","volume":"15","author":"L Gangoda","year":"2015","unstructured":"Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S. Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics. 2015;15(2\u20133):260\u201371.","journal-title":"Proteomics."},{"issue":"15","key":"735_CR34","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jacc.2015.02.026","volume":"65","author":"JM Vicencio","year":"2015","unstructured":"Vicencio JM, Yellon DM, Sivaraman V, Das D, Boi-Doku C, Arjun S, et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol. 2015;65(15):1525\u201336.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"735_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/cdd.2016.97","volume":"24","author":"V Rossi","year":"2017","unstructured":"Rossi V, Lispi M, Longobardi S, Mattei M, Di Rella F, Salustri A, et al. LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse. Cell Death Differentiation. 2017;24(1):72\u201382.","journal-title":"Cell Death Differentiation"},{"issue":"19","key":"735_CR36","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2217\/fon-2016-0176","volume":"12","author":"G Bedoschi","year":"2016","unstructured":"Bedoschi G, Navarro PA, Oktay K. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol. 2016;12(19):2333\u201344.","journal-title":"Future Oncol"},{"issue":"12","key":"735_CR37","first-page":"2926","volume":"30","author":"A Yuksel","year":"2015","unstructured":"Yuksel A, Bildik G, Senbabaoglu F, Akin N, Arvas M, Unal F, et al. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells. Hum Reprod. 2015;30(12):2926\u201335.","journal-title":"Hum Reprod"},{"issue":"6","key":"735_CR38","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/humrep\/dem027","volume":"22","author":"D Meirow","year":"2007","unstructured":"Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod. 2007;22(6):1626\u201333.","journal-title":"Hum Reprod"},{"key":"735_CR39","first-page":"CD008018","volume":"3","author":"H Chen","year":"2019","unstructured":"Chen H, Xiao L, Li J, Cui L, Huang W. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev. 2019;3:CD008018.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"735_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/humupd\/dmn022","volume":"14","author":"Z Blumenfeld","year":"2008","unstructured":"Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update. 2008;14(6):543\u201352.","journal-title":"Hum Reprod Update"},{"issue":"9","key":"735_CR41","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/annonc\/mdt196","volume":"24","author":"N Turner","year":"2013","unstructured":"Turner N, Partridge A, Sanna G, Di Leo A, Biganzoli L. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain. Ann Oncol. 2013;24(9):2224\u201335.","journal-title":"Ann Oncol"},{"issue":"11","key":"735_CR42","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jamaneurol.2016.3185","volume":"73","author":"J Middeldorp","year":"2016","unstructured":"Middeldorp J, Lehallier B, Villeda SA, Miedema SS, Evans E, Czirr E, et al. Preclinical assessment of young blood plasma for Alzheimer disease. JAMA neurology. 2016;73(11):1325\u201333.","journal-title":"JAMA neurology"},{"key":"735_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fphys.2018.00152","volume":"9","author":"I Kalampouka","year":"2018","unstructured":"Kalampouka I, van Bekhoven A, Elliott BT. Differing effects of younger and older human plasma on C2C12 myocytes in vitro. Front Physiol. 2018;9:152.","journal-title":"Front Physiol"},{"issue":"7","key":"735_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.7205\/MILMED-D-13-00336","volume":"179","author":"JR Evanson","year":"2014","unstructured":"Evanson JR, Guyton MK, Oliver DL, Hire JM, Topolski RL, Zumbrun SD, et al. Gender and age differences in growth factor concentrations from platelet-rich plasma in adults. Mil Med. 2014;179(7):799\u2013805.","journal-title":"Mil Med"},{"issue":"7","key":"735_CR45","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1210\/en.2014-1890","volume":"156","author":"ME Nilsson","year":"2015","unstructured":"Nilsson ME, Vandenput L, Tivesten \u00c5, Norl\u00e9n A-K, Lagerquist MK, Windahl SH, et al. Measurement of a comprehensive sex steroid profile in rodent serum by high-sensitive gas chromatography-tandem mass spectrometry. Endocrinology. 2015;156(7):2492\u2013502.","journal-title":"Endocrinology."},{"issue":"2","key":"735_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.beem.2010.11.004","volume":"25","author":"AB Araujo","year":"2011","unstructured":"Araujo AB, Wittert GA. Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab. 2011;25(2):303\u201319.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"735_CR47","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10815-007-9154-5","volume":"24","author":"J Wu","year":"2007","unstructured":"Wu J, Xu B, Wang W. Effects of luteinizing hormone and follicle stimulating hormone on the developmental competence of porcine preantral follicle oocytes grown in vitro. J Assist Reprod Genet. 2007;24(9):419\u201324.","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"735_CR48","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/endo.137.4.8625923","volume":"137","author":"SY Chun","year":"1996","unstructured":"Chun SY, Eisenhauer KM, Minami S, Billig H, Perlas E, Hsueh A. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology. 1996;137(4):1447\u201356.","journal-title":"Endocrinology."},{"issue":"3","key":"735_CR49","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1210\/en.2005-1281","volume":"147","author":"M Tsai-Turton","year":"2006","unstructured":"Tsai-Turton M, Luderer U. Opposing effects of glutathione depletion and follicle-stimulating hormone on reactive oxygen species and apoptosis in cultured preovulatory rat follicles. Endocrinology. 2006;147(3):1224\u201336.","journal-title":"Endocrinology."},{"issue":"6","key":"735_CR50","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1210\/endo.140.6.6931","volume":"140","author":"R Robles","year":"1999","unstructured":"Robles R, Tao X-J, Trbovich AM, Maravei DV, Nahum R, Perez GI, et al. Localization, regulation and possible consequences of apoptotic protease-activating factor-1 (Apaf-1) expression in granulosa cells of the mouse ovary. Endocrinology. 1999;140(6):2641\u20134.","journal-title":"Endocrinology."},{"issue":"3","key":"735_CR51","doi-asserted-by":"publisher","first-page":"R141","DOI":"10.1530\/JOE-14-0296","volume":"222","author":"H Prizant","year":"2014","unstructured":"Prizant H, Gleicher N, Sen A. Androgen actions in the ovary: balance is key. J Endocrinol. 2014;222(3):R141\u2013R51.","journal-title":"J Endocrinol"},{"key":"735_CR52","doi-asserted-by":"publisher","first-page":"818010","DOI":"10.1155\/2014\/818010","volume":"2014","author":"CG Gerv\u00e1sio","year":"2014","unstructured":"Gerv\u00e1sio CG, Bernuci MP, Silva-de-S\u00e1 MF, ACJdS R-e-S. The role of androgen hormones in early follicular development. ISRN Obstet Gynecol. 2014;2014:818010.","journal-title":"ISRN Obstet Gynecol"},{"issue":"5","key":"735_CR53","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11596-015-1497-z","volume":"35","author":"T Liu","year":"2015","unstructured":"Liu T, Cui Y-q, Zhao H, Liu H-b, Zhao S-d, Gao Y, et al. High levels of testosterone inhibit ovarian follicle development by repressing the FSH signaling pathway. Journal of Huazhong University of Science and Technology [Medical Sciences]. J Huazhong Univ Sci Technolog Med Sci. 2015;35(5):723\u20139.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"735_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/jrf.0.1030047","volume":"103","author":"K Lederer","year":"1995","unstructured":"Lederer K, Luciano A, Pappalardo A, Peluso J. Proliferative and steroidogenic capabilities of rat granulosa cells of different sizes. Reproduction. 1995;103(1):47\u201354.","journal-title":"Reproduction."}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-020-00735-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T17:02:37Z","timestamp":1606323757000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00735-3","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"13 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Shiraz University of Medical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}